Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis – New England Journal of Medicine Commentary on Twitter Original Article: Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis (IMPALA Trial) #ERScongress — NEJM (@NEJM) September 7, 2020
The post #ERScongress – [Abstract Only] Inhaled Molgramostim therapy in autoimmune pulmonary alveolar proteinosis appeared first on Links Medicus.